financetom
Business
financetom
/
Business
/
KeyCorp profit falls as higher deposit costs hurt interest income
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KeyCorp profit falls as higher deposit costs hurt interest income
Apr 18, 2024 4:59 AM

April 18 (Reuters) - KeyCorp ( KEY ) reported a 33.5%

drop in first-quarter profit on Thursday as its net interest

income was eroded by higher deposit costs and elevated interest

rates kept borrowers on the sidelines.

U.S. banks have been grappling with increased funding costs

as elevated interest rates prompt customers to move cash from

banks to safe-haven higher-yielding alternatives like

money-market funds for better returns.

Net interest income (NII), or the difference between what a

bank earns on loans and pays out on deposits, fell 20% to $886

million in the quarter.

Net interest margin in the first quarter contracted to 2.02%

versus 2.47% in the year-ago period.

The bank kept its forecast of NII declining between 2% and

5% in 2024 unchanged. Analysts on average expect it to fall

3.4%, according to LSEG data.

Meanwhile, loan growth has also receded as higher benchmark

lending rates keep borrowers on the sidelines. In recent weeks,

analysts have pushed back expectations of interest rate cuts

this year due to strong economic data.

KeyCorp's ( KEY ) average loans and leases decreased $2.6 billion,

or 6.1% in the quarter versus a year earlier.

It maintained its forecast of average loans declining

between 5% and 7% this year.

The company's net income fell to $183 million, or 20 cents

per share, in the three months ended March 31 from $275 million,

or 30 cents per share, in the year-ago period.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows
Aclaris Therapeutics Q3 revenue beats estimates, net loss narrows
Nov 6, 2025
Overview * Aclaris Q3 revenue beats analyst expectations despite a year-over-year decline * Net loss for Q3 smaller than expected, reflecting better financial performance * Company reports positive Phase 2a trial results for ATI-2138 in atopic dermatitis Outlook * Aclaris plans Phase 2 trial of ATI-2138 in H1 2026 for new indications * Company expects Phase 1b trials of ATI-052...
FHLBank Chicago Awards $52 Million in Affordable Housing Grants to Strengthen Communities throughout Illinois and Wisconsin
FHLBank Chicago Awards $52 Million in Affordable Housing Grants to Strengthen Communities throughout Illinois and Wisconsin
Nov 6, 2025
Program Provides Annual Grants to Subsidize the Acquisition, New Construction and/or Rehabilitation of Affordable Rental or Owner-Occupied Housing CHICAGO--(BUSINESS WIRE)-- The Federal Home Loan Bank of Chicago (FHLBank Chicago) today announced it has awarded $52 million through its 2025 Affordable Housing Program (AHP) General Fund round to help finance 37 housing projects located in Illinois and Wisconsin. This funding...
ProQR Q3 revenue misses estimates, reports net loss
ProQR Q3 revenue misses estimates, reports net loss
Nov 6, 2025
Overview * ProQR Q3 revenue missed analyst expectations * Company reported a net loss of €11 mln for Q3 2025 * ProQR received CTA authorization for Phase 1 trial of AX-0810 Outlook * ProQR expects initial safety data for AX-0810 by end of 2025 * Target engagement data for AX-0810 expected in H1 2026 Result Drivers * CASH POSITION -...
Viatris Q3 revenue and adjusted EPS beat estimates, helped by Aculys Pharma acquisition
Viatris Q3 revenue and adjusted EPS beat estimates, helped by Aculys Pharma acquisition
Nov 6, 2025
Overview * Viatris Q3 2025 revenue beats analyst expectations, adjusted EPS also exceeds estimates * Company acquires Aculys Pharma, gaining rights to pitolisant and Spydia in Japan * Company returns over $920 mln to shareholders, including $500 mln in share repurchases Outlook * Viatris ( VTRS ) raises 2025 revenue guidance to $13.9 bln-$14.3 bln * Company estimates 2025 adjusted...
Copyright 2023-2026 - www.financetom.com All Rights Reserved